Sanofi Provides Unprecedented Access to its Insulins for One Set Monthly Price

Sanofi continues its commitment to helping reduce cost burden for people living with diabetes with first-ever insulin savings program

Originally Published by Sanofi.

Starting in June, Sanofi will further expand its innovative Insulins Valyou Savings Program so people living with diabetes in the United States can pay $99 to access their Sanofi insulins* with a valid prescription, for up to 10 boxes of pens and/or 10 mL vials per month. The expansion of this program helps to address the challenge too many patients face regarding unpredictable and unaffordable pricing for their insulin.

“It is unacceptable to Sanofi that some people living with diabetes are struggling to pay for their insulin, so we have moved to act creatively and aggressively to help address affordability and access needs,” said Michelle Carnahan, Head of North America Primary Care at Sanofi. “By giving those who require both long-acting and/or mealtime insulins or use more than one box of pens or one vial per month access to their insulins for one flat price, we aim to help limit the burden on the individuals who have high out-of-pocket costs at the pharmacy counter.”

People exposed to high out-of-pocket prices at the pharmacy counter can participate in the Insulins Valyou Savings Program regardless of income level. This includes those who are paying high retail prices for their insulin and those who don’t qualify for other patient assistance programs.

Under current government regulations, pharmaceutical companies cannot offer this type of program to patients insured under Medicare, Medicaid, or similar federal or state programs, though Sanofi supports changing rules to expand this access program to all those who might benefit.

Kelly L. Close, co-founder, The diaTribe Foundation, and president, Close Concerns, said, “Sanofi is taking this vital, transformational action to make its insulins more affordable through this program. The U.S. diabetes community is in the middle of a crisis, because our dysfunctional healthcare system doesn’t allow equal, affordable, access to insulin. As patient advocates at diaTribe, we have been strongly urging manufacturers, insurers, healthcare providers, pharmacy benefit managers – and the government – to work together to help alleviate this problem. Today, we recognize Sanofi for their outstanding leadership in order to make their insulins available at a better price for all, regardless of income or dosing needs.”

A year ago, Sanofi launched the Insulins Valyou Savings Program to enable those who pay cash to pay the set prices of $99 for one 10mL vial or $149 for a box of pens. Now, up to 10 boxes of pens and/or 10mL vials will cost $99 per month.

Since it was launched last April, the program has resulted in approximately $10 million in patient savings. The program is available at U.S. pharmacies.

“As premiums on insurance plans continue to climb, some people living with diabetes have had to exit the higher premiums so they can find ways to pay less. The result may be the loss of prescription benefits,” said Lon Chenowith, who has been living with diabetes for more than 30 years. “That was what I was forced to do last year. Sanofi has savings programs for people who have been prescribed their insulin that can help them save on prescription costs. They have been a big encouragement to people like me.”

For more information or to learn how to access this program, visit www.InsulinsValYOU.com.

Additional patient resources available for accessing Sanofi medicines

Sanofi continues to offer other resources to make insulins more accessible including co-pay cards which may limit out-of-pocket expenses sometimes to $0 for all commercially insured patients regardless of income level. In addition, Sanofi offers assistance programs that provide medications, including insulin, at no charge for qualified low-income, uninsured patients through the patient assistance component of the Sanofi Patient Connection program. Together, these programs demonstrate the company’s dedication to finding support to help people living with diabetes gain access to the insulins they need.

Sanofi also encourages anyone who is prescribed a Sanofi medicine who may be having financial challenges or trouble navigating their insurance, to call Sanofi Patient Connection at (888) 847-4877 where eligible patients can be connected to the medicines and resources they need at no cost.

* The Insulins Valyou Savings Program does not include Sanofi’s combination insulin product.

Latest News

Inherent Racism Revealed in COVID-19 Vaccine Trials; Texas Sheriff Charged in Death of Javier Ambler While in Police Custody; AOC Attacks Trump Over $70k Spent on His Hair; and More

Major COVID-19 vaccine trials currently underway lack racial inclusion. The research being carried out in search of a vaccine for COVID-19 contains a startling lack of diversity, according to a new story from Fast Company’s Kristin Toussaint. While the stats on COVID-19’s attack on people of color continue to alarm…

Anti-Asian Racism in the United States Continues to Soar as a Result of Attitudes Over COVID-19; the Myth of ‘Defund the Police’; and More

Pandemic continues to cause soaring levels of anti-Asian racism. It was only a matter of time: the White House’s constant referral to COVID-19 as the “China Virus” has indeed caused a tidal wave of continuing racism against people of Asian ancestry, according to a new report published in the American…

Biden Stands by His Commitment to LGBTQ rights; Cost of Racism in the U.S. Tops $16 Trillion; Black and Latinx Continue to Die from COVID-19 at Nearly Twice the Rate of Whites; and More

Biden reaffirms commitment to LGBTQ rights; promises to pass Equality Act. Democratic presidential nominee Joe Biden doubled down on his promises to the LGBTQ community while speaking at a presidential town hall for the Human Rights Campaign Foundation on Sept. 24. “You deserve a partner in the White House to…

degeneres, work, show

Leadership Lessons to be Gleaned from Ellen DeGeneres’ Toxic Workplace Scandal

Ellen DeGeneres began her daytime talk show’s 18th season with an apology after a summer of allegations against her that claimed her show promoted a toxic work environment rife with racism, sexual misconduct and other mistreatment. In August 2020, three senior producers — executive producers Ed Glavin and Kevin Leman…

COVID entrepreneur

Explosive New Growth in Small Businesses Due to COVID-19; America’s Police Force is Not Becoming More Diverse Despite BLM Movement; the Best and Worst Performing States in the 2020 Census; and More

Even with incredible nationwide unemployment rates, the creation of new small and diverse businesses has exploded due to COVID-19. Finally some news coming out of our pandemic: The Philadelphia Tribune reports that as bars and restaurants closed and stay-at-home orders were put into place earlier in 2020 to help fight…

Justice for Breonna not served; The essential rule of politics; Teen serves two months in jail for not doing homework; and More

Justice for Breonna not served as grand jury indicted officer who shot her with wanton endangerment — but not murder. “Outrageous and offensive.” Those were  by attorney to the family, Ben Crump to describe the grand jury’s decision in the March 13 fatal police shooting of 26-year-old Breonna Taylor. While…